$TMDX TransMedics remains a high-growth transplant-technology story built around portable organ perfusion. The company announced a CFO transition effective Sept

Instant Stock Alerts • 2026-09-22 17:31 UTC • By Billy Odell Tucker-Robinson

$TMDX TransMedics remains a high-growth transplant-technology story built around portable organ perfusion. The company announced a CFO transition effective September 21 and reiterated its full-year 2026 revenue guidance.

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly